Polycystic ovary syndrome and fibrocystic breast disease: Is there any association?

Archives of Gynecology and Obstetrics

Volumn 280, Issue 2, 2009, Pages 249-253

  Gumus, Ilknur Inegol ^a   Koktener, Asli ^a   Dogan, Dilek ^a   Turhan, Nilgun Ozturk ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

Fibrocystic breast disease; Polycystic ovary syndrome

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOMAMMOGRAPHY; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; RISK FACTOR; ULTRASOUND;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 68149108625     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0889-8     Document Type: Article

References (39)

1. DW Polson J Adamas J Wadsworth S Franks 1988 Polycystic ovaries-a common finding in normal women Lancet 1 870 872 10.1016/S0140-6736(88)91612-1 (Pubitemid 18092411)
2. CG Solomon 1999 The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks Endocrinol Metab Clin North Am 28 247 263 10.1016/S0889-8529(05)70069-4
3. RA Lobo E Carmina 2000 The importance of diagnosing the polycystic ovary syndrome Ann Intern Med 132 989 993 (Pubitemid 30397600)
4. M Asuncion RM Calvo JL San Millan J Sancho S Avila HF Escobar-Morreale 2000 A prospective study of the prevalenceof the polycystic ovary syndrome in unselected Caucasianwomen from Spain J Clin Endocrinol Metab 85 2434 2438 10.1210/jc.85.7.2434
5. A Gadducci A Gargini E Palla A Fanucchi AR Genazzani 2005 Polycystic ovary syndrome and gynecological cancer: is there a link? Gynecol Endocrinol 20 200 208 10.1080/09513590400021201
6. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group 2003 Revised consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41 47 10.1093/humrep/deh098
7. A Gorins C Denis 1995 Effects of progesterone and progestational hormones on the mammary gland Arch Anat Cytol Pathol 43 28 35
8. JC Thalaband R Sitruk-Ware F Kuttenn P Mauvais-Jarvis 1986 Endocrine markers in benign breast diseases Zentralbl Gynakol 108 354 358 (Pubitemid 16060625)
9. R D'Amelio M Farris S Grande E Feraudo A Iuliano L Zichella 2001 Association between polycystic ovary and fibrocystic breast disease Gynecol Obstet Invest 51 134 137 10.1159/000052909
10. A Soran EO Talbott JV Zborowski JW Wilson 2005 The prevalence of benign breast disease in women with polycystic ovary syndrome: a reviewe of a 12-year follow-up Int J Clin Pract 59 795 797 10.1111/j.1742-1241.2005.00417.x
11. A Dunaif 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 774 800 10.1210/er.18.6.774
12. RA Lobo 1995 A disorder without identiy: 'HCA', 'PCO', 'PCOD', 'PCOS', 'SLS'. What are we to call it? Fertil Steril 63 1158 1160
13. J Devit 1981 Clinical benign disorders of the breast and carcinoma of the breast Surg Gynecol Obstet 152 437 440
14. SA Feig 1989 The role of ultrasound in a breast imaging center Semin Ultrasound CT MR 10 90 105 (Pubitemid 19110328)
15. SVW Hilton GR Leopold LK Olson 1986 Real-time breast sonography: application in 300 consecutive patients AJR 147 479 486 (Pubitemid 16013431)
16. KE Anderson TA Sellers PL Chen SS Rich CP Hong AR Folsom 1997 Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa Cancer 79 494 499 10.1002/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z
17. Mauvais-Jarvis P Sitruk-Ware R, Kutten F, Sterkers N (1979) Luteal phase insufficiency: a common pathophysiological factor in development of benign and malignant breast disease. In: Bulbrook RD, Taylor DJ (eds) Commentaries on research in breast disease, Alan R. Liss, New York, pp 25-29
18. L Dogliotti F Orlandi A Angeli 1989 The endocrine basis of benign breast disorders World J Surg 13 674 679 10.1007/BF01658413 (Pubitemid 20077138)
19. LR Sitruk-Ware N Sterkers I Mowszowics P Mauvais-Jarvis 1977 Inaequate corpus luteal function in women with benign breast disease J Clin Endocrinol Metab 44 771
20. Torris R, Parodi S, Fontana V, Pensa F, Casella C, Barreca A, De Palo G, Costa A, Decensi A (1998) Effects of fenretinine on plasma IGF-1 and IGFBP-3 in early breast cancer patients. Int J Cancer 76:787-790. doi:10.1002/(SICI)1097- 0215(19980610)76:6<787::AID-IJC3>3.0.CO;2-U
21. G Gebauer W Jager N Lang 1998 mRNA expression of components of the insulin-like growth factor system in breast cell lines, tissues and metastatic breast cancer cells Anticancer Res 18 1991 1995
22. EH Ng CY Ji PH Tan V Lin KC Soo KO Lee 1998 Altered serum levels of insulin-like growth-factor binding protein in breast cancer patients Ann Surg Oncol 5 194 201 10.1007/BF02303854
23. PM Spritzer DM Morsch D Witgen 2005 Polycystic ovary syndrome associated neoplasms Arq Bras Endocrinol Metabol 49 805 810 10.1590/S0004-27302005000500022
24. A Gadducci A Gargini E Palla A Fanucchi AR Genazzani 2005 Polycystic ovary syndrome and gynecological cancer: is there a link? Gynecol Endocrinol 20 200 208 10.1080/09513590400021201
25. J Lefebvre 1997 The protein of fibrocystic breast disease-methods of measurement and clinical implications Bull Acad Natl Med 181 1487 1500
26. JC Thalaband R Sitruk-Ware F Kuttenn P Mauvais-Jarvis 1986 Endocrine markers in benign breast diseases Zentralbl Gynakol 108 354 358 (Pubitemid 16060625)
27. V Panaritis P Despotidis A Kyriakidis 2004 Diameter of mammary terminal ducts as an additional tool in evaluation of women with polycystic ovarium disease Arch Gynecol Obstet 270 252 254 10.1007/s00404-003-0555-0
28. A Soran EO Talbott JV Zborowski JW Wilson 2005 The prevalence of benign breast disease in women with polycystic ovary syndrome: a reviewe of a 12-year follow-up Int J Clin Pract 59 795 797 10.1111/j.1742-1241.2005.00417.x
29. R D'Amelio M Farris S Grande E Feraudo A Iuliano 2000 Incidence of fibrocystic disease of the breast in women with polycystic ovary. Clinico-instrumental study Minerva Ginecol 52 321 325 (Pubitemid 33615237)
30. S Wild T Pierpoint H Jacobs P McKeigue 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study Hum Fertil 3 101 105 10.1080/1464727002000198781 (Pubitemid 30678869)
31. A Balen 2001 Polycystic ovary syndrome and cancer Hum Reprod Update 7 522 525 10.1093/humupd/7.6.522
32. WU Atiomo E El-Mahdi P Hardiman 2003 Familial associations in women with polycystic ovary syndrome Fertil Steril 80 143 145 10.1016/S0015-0282(03)00502-8
33. MD Gammon WD Thompson 1991 Polycystic ovaries and the risk of breast cancer Am J Epidemiol 134 818 824
34. KE Anderson TA Sellers PL Chen SS Rich CP Hong AR Folsom 1997 Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa Cancer 79 494 499 10.1002/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z
35. WU Atiomo E El-Mahdi P Hardiman 2003 Familial associations in women with polycystic ovary syndrome Fertil Steril 80 143 145 10.1016/S0015-0282(03)00502-8
36. S Wild T Pierpoint H Jacobs P McKeigue 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study Hum Fertil 3 101 105 10.1080/1464727002000198781 (Pubitemid 30678869)
37. LC Hartmann TA Sellers MH Frost WL Lingle AC Degnim K Ghosh RA Vierkant 2005 Benign breast disease and the risk of breast cancer N Engl J Med 353 229 237 10.1056/NEJMoa044383
38. YC Wong B Xie 2001 The role of androgens in mammary carcinogenesis Ital J Anat Embryol 106 111 125
39. B Xie SW Tsao YC Wong 1999 Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens Carcinogenesis 20 1597 1606 10.1093/carcin/20.8.1597